Lung Cancer Clinical Trial

A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

Summary

The purpose of this study is to isolate and measure circulating tumor cells in the blood stream to advance detection of cancer and treatment monitoring. In this study, the investigators will utilize the novel technology for circulating tumor cell detection in order to evaluate their presence in patients with lung cancer.

View Full Description

Full Description

The plan is to collect both blood and tumor samples from the patient's lung cancer in order to validate this technology in detecting circulating tumor cells. The investigators will also obtain a postoperative blood sample to see if there is a decrease in the overall circulating tumor cell measurement once the tumor has been surgically removed.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Stage IB and above non-small cell lung cancer or metastatic lung cancer
Age >18 years old
Willing and able to consent to study
No prior history of neoadjuvant therapy.

Exclusion Criteria:

Age <18 years old
Unable to provide consent

Study is for people with:

Lung Cancer

Estimated Enrollment:

23

Study ID:

NCT02370303

Recruitment Status:

Completed

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic in Rochester
Rochester Minnesota, 55905, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

23

Study ID:

NCT02370303

Recruitment Status:

Completed

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider